0001437749-23-015185.txt : 20230519 0001437749-23-015185.hdr.sgml : 20230519 20230519084500 ACCESSION NUMBER: 0001437749-23-015185 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230517 FILED AS OF DATE: 20230519 DATE AS OF CHANGE: 20230519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STRATTAN CE RICK CENTRAL INDEX KEY: 0000943648 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39780 FILM NUMBER: 23937977 MAIL ADDRESS: STREET 1: 4123 NW 46TH AVE CITY: GAINSVILLE STATE: FL ZIP: 32606 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclo Therapeutics, Inc. CENTRAL INDEX KEY: 0000922247 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 593029743 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6714 NW 16TH STREET, SUITE B CITY: GAINESVILLE STATE: FL ZIP: 32653 BUSINESS PHONE: 386-418-8060 MAIL ADDRESS: STREET 1: PO BOX 1180 CITY: ALACHUA STATE: FL ZIP: 32616-1180 FORMER COMPANY: FORMER CONFORMED NAME: CTD HOLDINGS INC DATE OF NAME CHANGE: 20000913 FORMER COMPANY: FORMER CONFORMED NAME: CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC DATE OF NAME CHANGE: 19941012 4 1 rdgdoc.xml FORM 4 X0407 4 2023-05-17 0000922247 Cyclo Therapeutics, Inc. CYTH 0000943648 STRATTAN CE RICK 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 1 0 Common Stock 2023-05-17 4 A 0 21360 0 A 220736 D Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the fourth quarter of 2022 and first quarter of 2023. The number of shares received in lieu of cash was calculated based on the closing price of 1.03 per share of common stock on May 16, 2023. /s/ C.E. Rick Strattan 2023-05-18